Topical iodine facilitates transdermal delivery of insulin

Journal of Controlled Release

Volumn 118, Issue 2, 2007, Pages 185-188

  Sintov, Amnon C ^a   Wormser, Uri ^b  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Diabetes; Insulin; Iodine; Transdermal delivery

Indexed keywords

AMINO ACIDS; CONTROLLED DRUG DELIVERY; GLUCOSE; HORMONES; IODINE; PATIENT TREATMENT; SKIN;

DIABETIC PATIENTS; ENDOGENOUS SULFHYDRYLS; GAMMA GLUTAMYLCYSTEINE; TRANSDERMAL DELIVERY;

INSULIN;

ISOPHANE INSULIN; POVIDONE IODINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; FEMALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, TOPICAL; ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DIPEPTIDES; GLUTATHIONE; HYPOGLYCEMIC AGENTS; INSULIN; MALE; OXIDANTS; POVIDONE-IODINE; RATS; RATS, SPRAGUE-DAWLEY; SKIN; SKIN ABSORPTION;

EID: 33847394433     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2006.12.006     Document Type: Article

References (27)

1. Shaikh I.M., Jadhav K.R., Ganga S., Kadam V.J., and Pisal S.S. Advanced approaches in insulin delivery. Curr. Pharm. Biotechnol. 6 (2005) 387-395
2. Hoffman A., and Ziv E. Pharmacokinetic considerations of new insulin formulations and routes of administration. Clin. Pharmacokinet. 33 (1997) 285-301
3. Chetty D.J., and Chien Y.W. Novel methods of insulin delivery: an update. Crit. Rev. Ther. Drug Carr. Syst. 15 (1998) 629-670
4. Hosny E.A., Ghilzai N.M., Al-Najar T.A., and Elmazar M.M. Hypoglycemic effect of oral insulin in diabetic rabbits using pH-dependent coated capsules containing sodium salicylate without and with sodium cholate. Drug Dev. Ind. Pharm. 24 (1998) 307-311
5. Whitehead K., Shen Z., and Mitragotri S. Oral delivery of macromolecules using intestinal patches: applications for insulin delivery. J. Control. Release 98 (2004) 37-45
6. Cui F., Shi K., Zhang L., Tao A., and Kawashimam Y. Biodegradable nanoparticles loaded with insulin-phospholipid complex for oral delivery: preparation, in vitro characterization and in vivo evaluation. J. Control. Release 114 (2006) 242-250
7. Bechgaard E., Gizurarson S., Hjortkjaer R.K., and Sorensen A.R. Intranasal administration of insulin to rabbits using glycofurol as an absorption promoter. Int. J. Pharm. 128 (1996) 287-289
8. Leary A.C., Stote R.M., Breedt H.J., O'Brien J., and Buckley B. Pharmacokinetics and pharmacodynamics of intranasal insulin administered to healthy subjects in escalating doses. Diabetes Technol. Ther. 7 (2005) 124-130
9. Huang Y.Y., and Wang C.H. Pulmonary delivery of insulin by liposomal carriers. J. Control. Release 113 (2006) 9-14
10. Shojaei A.H. Buccal mucosa as a route for systemic drug delivery: a review. J. Pharm. Pharm. Sci. 1 (1998) 15-30
11. Golomb G., Avramoff A., and Hoffman A. A new route of drug administration: intrauterine delivery of insulin and calcitonin. Pharm. Res. 10 (1993) 828-833
12. King M.J., Badea I., Solomon J., Kumar P., Gaspar K.J., and Foldvari M. Transdermal delivery of insulin from a novel biphasic lipid system in diabetic rats. Diabetes Technol. Ther. 4 (2002) 479-488
13. Guo J., Ping Q., and Zhang L. Transdermal delivery of insulin in mice by using lecithin vesicles as a carrier. Drug Deliv. 7 (2000) 113-116
14. Kanikkannan N., Singh J., and Ramarao P. Transdermal iontophoretic delivery of bovine insulin and monomeric human insulin analogue. J. Control. Release 59 (1999) 99-105
15. Mitragotri S., Blankschtein D., and Langer R. Ultrasound-mediated transdermal protein delivery. Science 269 (1995) 850-853
16. Boucaud A., Garrigue M.A., Machet L., Vaillant L., and Patat F. Effect of sonication parameters on transdermal delivery of insulin to hairless rats. J. Control. Release 81 (2002) 113-119
17. Sen A., Daly M.E., and Hui S.W. Transdermal insulin delivery using lipid enhanced electroporation. Biochim. Biophys. Acta 1564 (2002) 5-8
18. Lee S., McAuliffe D.J., Mulholland S.E., and Doukas A.G. Photomechanical transdermal delivery of insulin in vivo. Lasers Surg. Med. 28 (2001) 282-285
19. Pillai O., Nair V., and Panchagnula R. Transdermal iontophoresis of insulin: IV. Influence of chemical enhancers. Int. J. Pharm. 269 (2004) 109-120
20. Pillai O., Borkute S.D., Sivaprasad N., and Panchagnula R. Transdermal iontophoresis of insulin. II. Physicochemical considerations. Int. J. Pharm. 254 (2003) 271-280
21. Cevc G. Transdermal drug delivery of insulin with ultradeformable carriers. Clin. Pharmacokinet. 42 (2003) 461-474
22. Higaki M., Kameyama M., Udagawa M., Ueno Y., Yamaguchi Y., Igarashi R., Ishihara T., and Mizushima Y. Transdermal delivery of CaCO(3)-nanoparticles containing insulin. Diabetes Technol. Ther. 8 (2006) 369-374
23. Rafter G.W. Reaction of insulin with reduced glutathione. Biochem. Int. 20 (1990) 817-820
24. Wroblewski V.J., Masnyk M., Khambatta S.S., and Becker G.W. Mechanism involved in degradation of human insulin by cytosolic fractions of human, monkey, and rat liver. Diabetes 41 (1992) 539-547
25. Yan C.C., and Huxtable R.J. Fluorimetric determination of monobromobimane and o-phthalaldehyde adducts of γ-glutamylcysteine and glutathione: application to assay of γ-glutamylcysteinyl synthetase activity and glutathione concentration in liver. J. Chromatogr., B, Biomed. Sci. Appl. 672 (1995) 217-224
26. Wormser U., Kohen R., Moor E.V., Eldad A., Gal R., Nyska A., and Brodsky B. Noninvasive procedure for in situ determination of skin surface aspartic proteinase activity in animals; implications to human skin. Arch. Dermatol. Res. 289 (1997) 686-691
27. Bernkop-Schnürch A., Kast C.E., and Guggi D. Permeation enhancing polymers in oral delivery of hydrophilic macromolecules: thiomer/GSH systems. J. Control. Release 93 (2003) 95-103